No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CRDO240719C25000
- 4.75
- -0.75-13.64%
15min DelayClose Jul 18 16:00 ET
5.00High4.70Low
5.00Open5.50Pre Close9 Volume210 Open Interest25.00Strike Price4.42KTurnover209.91%IV0.61%PremiumJul 19, 2024Expiry Date4.57Intrinsic Value100Multiplier1DDays to Expiry0.18Extrinsic Value100Contract SizeAmericanOptions Type0.9256Delta0.0392Gamma6.29Leverage Ratio-0.1290Theta0.0008Rho5.82Eff Leverage0.0024Vega
Intraday
- 5D
- Daily
News
Stifel Adjusts Price Target on Credo Technology Group to $36 From $30, Maintains Buy Rating
Credo Technology Group CRDO) has an average outperform rating and a price target range of $24 to $40, according to analysts polled by Capital IQ.Price: 28.80, Change: -1.65, Percent Change: -5.42
Credo Technology Is Maintained at Buy by Stifel
Credo Technology Is Maintained at Buy by
Stifel Maintains Credo Technology(CRDO.US) With Buy Rating, Raises Target Price to $36
Stifel analyst Tore Svanberg maintains $Credo Technology(CRDO.US)$ with a buy rating, and adjusts the target price from $30 to $36.According to TipRanks data, the analyst has a success rate of 64.8%
Express News | Credo Technology Group Holding Ltd : Stifel Raises Target Price to $36 From $30
Express News | Shares of Companies Within the Broader Technology Sector Are Trading Lower Amid a Selloff in Chips and AI-related Stocks
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) fell sharply during Wednesday's session after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for
Comments
Insiders selling shares may suggest satisfaction with a lower valuation, a concern for stakeholders. Absence of insider purchases over the year could indicate dwindling company confidence, despite high insider ownership signaling management shareholder alignment.
The recent insider selling could possibly hint at approval of a lower valuation. However, considerable insider ownership indicates all shareholders' interests are likely prioritized. But, absence of insider purchases recently, alongside insider sales, might destabilize confidence in firm's future.
ColumnsWhy AI is not a Bubble
The explosion of interest in AI that has dominated equity markets in recent months reflects the potential for new avenues of growth and, at the same time, the power of a stock market narrative to drive expectations.
While AI as a technology is not new, the interest around its potential has gathered momentum since the launch of ChatGPT. This exuberance has fuelled a re-rating in the technology sector overall, but particularly in the easier to identify ‘early winners’ — comp...
While AI as a technology is not new, the interest around its potential has gathered momentum since the launch of ChatGPT. This exuberance has fuelled a re-rating in the technology sector overall, but particularly in the easier to identify ‘early winners’ — comp...
+5
1
Read more